Quick Answer
Fortress Biotech, Inc. reported Total Revenue of $63.26 million for fiscal year 2025.
Fortress Biotech, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $63.26M | +9.7% |
| 2024 | $57.67M | -31.8% |
| 2023 | $84.51M | +11.6% |
| 2022 | $75.74M | +10.1% |
| 2021 | $68.79M | +50.9% |
| 2020 | $45.60M | +24.5% |
| 2019 | $36.63M | +36.3% |
| 2018 | $26.88M | +55.9% |
| 2017 | $17.25M | +4.6% |
| 2016 | $16.48M | +1809.6% |
| 2015 | $863.0K | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.63M | +20.5% | +7.4% |
| June 30, 2025 | $16.41M | +10.2% | +12.2% |
| September 30, 2024 | $14.63M | -57.9% | -1.8% |
| June 30, 2024 | $14.90M | -14.3% | +14.3% |
| March 31, 2024 | $13.03M | +4.8% | -62.5% |
| September 30, 2023 | $34.75M | +110.3% | +99.9% |
| June 30, 2023 | $17.39M | -7.9% | +39.9% |
| March 31, 2023 | $12.43M | -48.1% | -24.8% |
- Fortress Biotech, Inc. showed an increase of +9.7% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Fortress Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: